| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Zongwei Lin, Xinyu Zhang, Yan Liu, Dongxia Miao, Huanyi Zhang, Tao Zhang, Fenglei Zhang, Peng Li, Hongyan Dai, Guihua Jiang, Dongxia Zhang, Lin Zhong, Huixia Lu, Xiaoping J. Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study. ESC heart failure. 2024-09-03. PMID:39225306. |
screening for fabry disease in patients with left ventricular hypertrophy in china: a multicentre and prospective study. |
2024-09-03 |
2024-09-05 |
Not clear |
| Zongwei Lin, Xinyu Zhang, Yan Liu, Dongxia Miao, Huanyi Zhang, Tao Zhang, Fenglei Zhang, Peng Li, Hongyan Dai, Guihua Jiang, Dongxia Zhang, Lin Zhong, Huixia Lu, Xiaoping J. Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study. ESC heart failure. 2024-09-03. PMID:39225306. |
left ventricular hypertrophy (lvh) is frequently detected via echocardiography in individuals with fabry disease (fd), sometimes leading to confusion with hypertrophic cardiomyopathy (hcm) of other aetiologies. |
2024-09-03 |
2024-09-05 |
Not clear |
| Ching-Hui Huang, Chen-Ling Kuo, Yu-Shan Cheng, Ching-San Huang, Chin-San Liu, Chia-Chu Chan. Sphingolipid Metabolism Is Associated with Cardiac Dyssynchrony in Patients with Acute Myocardial Infarction. Biomedicines. vol 12. issue 8. 2024-08-29. PMID:39200328. |
cardiac dyssynchrony is observed in patients with fabry disease and left ventricular (lv) hypertrophy. |
2024-08-29 |
2024-09-01 |
Not clear |
| Cristina García Sebastián, Vicente Climent Payá, Juan Carlos Castillo, José Ángel Urbano-Moral, Aurora Ruz Zafra, María José Valle Caballero, José Luis Zamoran. Prevalence of Fabry disease in patients with left ventricular hypertrophy and renal involvement (PrEFaCe). Medicina clinica. 2024-08-28. PMID:39198113. |
prevalence of fabry disease in patients with left ventricular hypertrophy and renal involvement (preface). |
2024-08-28 |
2024-09-01 |
Not clear |
| Rosa Lillo, Maurizio Pieroni, Antonia Camporeale, Michele Ciabatti, Antonella Lombardo, Massimo Massetti, Francesca Grazian. Echocardiography in Anderson-Fabry Disease. Reviews in cardiovascular medicine. vol 23. issue 6. 2024-07-31. PMID:39077168. |
recently, advanced echocardiographic techniques, such as speckle tracking analysis, are offering new insights in the assessment of fabry disease patients and in the differential diagnosis of cardiomyopathies with hypertrophic phenotype. |
2024-07-31 |
2024-08-02 |
Not clear |
| Andrea Di Lenarda, Marco Cittar, Chiara Cappelletto, Luisa Mattei, Antonella Cherubini, Donatella Radini, Arjuna Scagnetto, Annamaria Iorio, Giulia Barbati, Giorgio Faganello, Giulia Russ. [Focus on heart failure with preserved ejection fraction: from trials to the real world of the Friuli-Venezia Giulia Cardiovascular Observatory]. Giornale italiano di cardiologia (2006). vol 25. issue 8. 2024-07-29. PMID:39072594. |
recently, targeted therapies have been introduced for specific, albeit rare, phenotypes such as fabry disease, hypertrophic cardiomyopathy and amyloidosis. |
2024-07-29 |
2024-08-02 |
Not clear |
| Gabriela Neculae, Lucian Predescu, Oana Popa, Elena Rusu, Ruxandra Jurcu. Complex management of Fabry cardiomyopathy: a case report on the use of alcohol septal ablation and chaperone therapy. European heart journal. Case reports. vol 8. issue 7. 2024-07-18. PMID:39021360. |
cardiac involvement in fabry disease (fd) usually manifests as a concentric left ventricular hypertrophy with rare cases developing left ventricular outflow tract obstruction (lvoto), symptoms varying from fatigue and exercise associated dyspnoea to angina or arrhythmias. |
2024-07-18 |
2024-07-20 |
Not clear |
| Sophia Po-Yee Leung, Scott Dougherty, Xiao-Yu Zhang, Kevin K H Kam, Wai-Kin Chi, Joseph Y S Chan, Erik Fung, Jeffrey K T Wong, Paul C L Choi, David K H Chan, Bun Sheng, Alex Pui-Wai Le. The Asian Fabry Cardiomyopathy High-Risk Screening Study 2 (ASIAN-FAME-2): Prevalence of Fabry Disease in Patients with Left Ventricular Hypertrophy. Journal of clinical medicine. vol 13. issue 13. 2024-07-13. PMID:38999464. |
the asian fabry cardiomyopathy high-risk screening study 2 (asian-fame-2): prevalence of fabry disease in patients with left ventricular hypertrophy. |
2024-07-13 |
2024-07-15 |
Not clear |
| Gustavo Ferrari, Isaac Kisinovsky, Ricardo Reisin, Paula Rozenfeld, Pablo Neumann, Verónica Finn, Cintia Marchesoni, Pedro Quiet. Agalsidase alfa long-term effect on left ventricular hypertrophy in Fabry disease. Medicina. vol 84. issue 3. 2024-06-22. PMID:38907966. |
agalsidase alfa long-term effect on left ventricular hypertrophy in fabry disease. |
2024-06-22 |
2024-06-25 |
Not clear |
| Bernard P Paelinck, Antoine Bondue, Tomas Robyns, François Eysken. Left ventricular hypertrophy: do not forget Fabry disease. Diagnostic work-up and differential diagnosis. Acta cardiologica. 2024-06-13. PMID:38869089. |
left ventricular hypertrophy: do not forget fabry disease. |
2024-06-13 |
2024-06-15 |
Not clear |
| Niccolo Maurizi, Albina Nowak, Christiane Gruner, Mehdi Namdar, Christian Schmied, Alessandra Pia Porretta, Guillaume Barbey, Veronique Monzambani, Pierre Monney, Frédéric Barbe. Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy. Heart (British Cardiac Society). 2024-05-15. PMID:38749654. |
fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy. |
2024-05-15 |
2024-05-27 |
Not clear |
| Wei-Wen Chen, Ling Kuo, Yi-Xun Lin, Wen-Chung Yu, Chien-Chao Tseng, Yenn-Jiang Lin, Ching-Chun Huang, Shih-Lin Chang, Jacky Chung-Hao Wu, Chun-Ku Chen, Ching-Yao Weng, Siwa Chan, Wei-Wen Lin, Yu-Cheng Hsieh, Ming-Chih Lin, Yun-Ching Fu, Tsung Chen, Shih-Ann Chen, Henry Horng-Shing L. A Deep Learning Approach to Classify Fabry Cardiomyopathy from Hypertrophic Cardiomyopathy Using Cine Imaging on Cardiac Magnetic Resonance. International journal of biomedical imaging. vol 2024. 2024-05-06. PMID:38706878. |
a challenge in accurately identifying and classifying left ventricular hypertrophy (lvh) is distinguishing it from hypertrophic cardiomyopathy (hcm) and fabry disease. |
2024-05-06 |
2024-05-08 |
Not clear |
| Wei-Wen Chen, Ling Kuo, Yi-Xun Lin, Wen-Chung Yu, Chien-Chao Tseng, Yenn-Jiang Lin, Ching-Chun Huang, Shih-Lin Chang, Jacky Chung-Hao Wu, Chun-Ku Chen, Ching-Yao Weng, Siwa Chan, Wei-Wen Lin, Yu-Cheng Hsieh, Ming-Chih Lin, Yun-Ching Fu, Tsung Chen, Shih-Ann Chen, Henry Horng-Shing L. A Deep Learning Approach to Classify Fabry Cardiomyopathy from Hypertrophic Cardiomyopathy Using Cine Imaging on Cardiac Magnetic Resonance. International journal of biomedical imaging. vol 2024. 2024-05-06. PMID:38706878. |
our proposed system named the mri short-axis view left ventricular hypertrophy classifier (mslvhc) is a high-accuracy standardized imaging classification model developed using ai and trained on mri short-axis (sax) view cine images to distinguish between hcm and fabry disease. |
2024-05-06 |
2024-05-08 |
Not clear |
| Hao-Chih Chang, Ling Kuo, Shih-Hsien Sung, Dau-Ming Niu, Wen-Chung Y. Prognostic implications of left ventricular hypertrophy and mechanical function in Fabry disease: A longitudinal cohort study. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2024-05-04. PMID:38704103. |
prognostic implications of left ventricular hypertrophy and mechanical function in fabry disease: a longitudinal cohort study. |
2024-05-04 |
2024-05-07 |
Not clear |
| Hao-Chih Chang, Ling Kuo, Shih-Hsien Sung, Dau-Ming Niu, Wen-Chung Y. Prognostic implications of left ventricular hypertrophy and mechanical function in Fabry disease: A longitudinal cohort study. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2024-05-04. PMID:38704103. |
the prognostic value of different grades of left ventricular hypertrophy (lvh) and left ventricular (lv) mechanical function in fabry disease is unclear. |
2024-05-04 |
2024-05-07 |
Not clear |
| Emanuele Monda, Athanasios Bakalakos, Robin Lachmann, Petros Syrris, Giuseppe Limongelli, Elaine Murphy, Derralynn Hughes, Perry Mark Elliot. Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart (British Cardiac Society). 2024-04-30. PMID:38688703. |
incidence and risk factors for development of left ventricular hypertrophy in fabry disease. |
2024-04-30 |
2024-05-03 |
Not clear |
| Emanuele Monda, Athanasios Bakalakos, Robin Lachmann, Petros Syrris, Giuseppe Limongelli, Elaine Murphy, Derralynn Hughes, Perry Mark Elliot. Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart (British Cardiac Society). 2024-04-30. PMID:38688703. |
left ventricular hypertrophy (lvh) is the principal cardiac manifestation of fabry disease (fd). |
2024-04-30 |
2024-05-03 |
Not clear |
| Maria Chiara Meucci, Rosa Lillo, Federica Mango, Mario Marsilia, Giulia Iannaccone, Filippo Tusa, Marco Luigetti, Elena Biagini, Massimo Massetti, Gaetano Antonio Lanza, Antonella Lombardo, Francesca Grazian. Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis. International journal of cardiology. 2024-02-21. PMID:38382852. |
fabry disease (fd) and transthyretin cardiac amyloidosis (ttr ca) are cardiomyopathies with hypertrophic phenotype that share several features, including left atrial (la) enlargement and dysfunction, but direct comparative data are lacking. |
2024-02-21 |
2024-02-24 |
Not clear |
| Onur Akhan, Mehmet Kış, Tuncay Güzel, Mehdi Zogh. Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy. Arquivos brasileiros de cardiologia. vol 121. issue 1. 2024-02-07. PMID:38324858. |
differences between two distinct hypertrophic cardiac conditions: fabry disease versus hypertrophic cardiomyopathy. |
2024-02-07 |
2024-02-10 |
Not clear |
| Onur Akhan, Mehmet Kış, Tuncay Güzel, Mehdi Zogh. Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy. Arquivos brasileiros de cardiologia. vol 121. issue 1. 2024-02-07. PMID:38324858. |
hypertrophic cardiomyopathy (hcm) and fabry disease (fd) are genetically inherited diseases with left ventricular hypertrophy (lvh) phenotype characteristics that cause adverse cardiac outcomes. |
2024-02-07 |
2024-02-10 |
Not clear |